Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Steven A. Edmundowicz MD, MASGE Associate Editor

Scott J. Cotler MD Associate Editor

See All Experts

featured

Published in Gastroenterology

Journal Scan / Research · May 02, 2024

First-Time ERCP for Benign Indications More Than 1 Year After Cholecystectomy: Incidence and Outcomes

Clinical Gastroenterology and Hepatology

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Ayokunle Abegunde MD, MSc, MRCGP, FACP, FACG

Clinical Gastroenterology and Hepatology

Rise In First-Time ERCP For Benign Indications >1 Year After Cholecystectomy Is Associated With Worse Outcomes

Clin. Gastroenterol. Hepatol. 2024 Apr 08;[EPub Ahead of Print], NR Thiruvengadam, M Saumoy, DE Schaubel, PB Cotton, BJ Elmunzer, ML Freeman, S Varadarajulu, ML Kochman, GA Coté

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

First-Time ERCP for Benign Indications More Than 1 Year After Cholecystectomy: Incidence and Outcomes

Additional Info

Rise In First-Time ERCP For Benign Indications >1 Year After Cholecystectomy Is Associated With Worse Outcomes

Further Reading

Outcomes of Switch From Off-Label Swallowed Topical Corticosteroids to Budesonide Orodispersible Tablets in Patients With Eosinophilic Esophagitis

Management of Liver Transplant Candidates With a High Cardiac Risk

Clinical Practice Update on Management of Nonampullary Duodenal Lesions

MRI and High-Resolution Manometry to Predict Response to Bisacodyl and Hyoscine for Constipation

Association Between Vibration-Controlled Transient Elastography–Based Parameters and Clinical Outcomes in Liver Transplant Recipients

Distinct and Shared Features of Gastroparesis and Functional Dyspepsia

Intensified- vs Standard-Dose Infliximab Induction Therapy for Steroid-Refractory Acute Severe Ulcerative Colitis

Outcomes of an Intervention Combining Energy Restriction and Exercise in Patients With MASH

Clinical Management: Colorectal Intramucosal Carcinoma vs High-Grade Dysplasia and T1 Colorectal Cancer

Liver Transplantation in Patients With Wilson Disease: Current Knowledge and Future Perspectives

Association of Risankizumab Concentration and IL-22 Levels With Clinical and Biochemical Remission of Crohn's Disease

Recently Updated